Patient Satisfaction with Once-Daily Single-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (DRV/c/FTC/TAF): A Real-World Study of Patient Self-Reported Outcomes in HIV-1-Diagnosed Adults.
Joyce LaMoriAntoine SeignezLise RadoszyckiPublished in: Patient preference and adherence (2022)
DRV/c/FTC/TAF therapy was associated with high patient satisfaction and patients taking DRV/c/FTC/TAF had a moderate HIV symptom burden. Patient experience and health-related quality of life during HIV therapy are important metrics that may help healthcare providers increase patient adherence.
Keyphrases
- patient satisfaction
- antiretroviral therapy
- hiv positive
- hiv infected
- hiv testing
- human immunodeficiency virus
- hiv infected patients
- hepatitis c virus
- hiv aids
- healthcare
- men who have sex with men
- case report
- end stage renal disease
- newly diagnosed
- ejection fraction
- physical activity
- patient reported
- skeletal muscle
- risk factors
- glycemic control
- social media
- mesenchymal stem cells
- cell therapy
- replacement therapy
- smoking cessation